Management of ODS Regulatory Referenced Deliverables
Project Scope |
---|
The scope of this project is to identify a primary and back-up representative for each PHUSE regulatory referenced deliverable that will:
The project team will meet quarterly with the ODS Working Group Leads to discuss potential updates and their timing to avoid burdening the project team members and the regulatory authorities in reviewing the updated deliverables. |
Problem Statement |
---|
The Optimizing the Use of Data Standards Working Group is responsible for the maintenance of four regulatory referenced deliverables (the cSDRG, ADRG, SDSP and BDRG) as well as three that will be published in the future. There is no regular maintenance process for updating these deliverables due to updates to binding and non-binding guidance from regulatory authorities. The project teams that were formed to create the documents no longer meet on a regular basis. This project will address the issue of implementing scheduled updates to these deliverables. |
Problem Impact | |
---|---|
Regulatory authorities reference the deliverables within their guidance documents and the deliverables must be in alignment with the guidance documents. Stakeholders include regulatory authorities and organisations that create the regulatory referenced deliverables. The FDA expects sponsors to submit the deliverables using the templates that PHUSE creates. Included in the PHUSE deliverables are the templates, example documents and completion guidelines. |
Project Leads | |
---|---|
Janet Low, Merk | janet_low@merck.com |
Christine Rossin, Pfizer | Christine.Rossin@pfizer.com |
Nicola Newton, PHUSE Project Assistant |
CURRENT STATUS Q3 2024 |
---|
|
Regulatory Referenced Deliverables | Representatives |
---|---|
Sumit Pradhan, Syneos Health and Pradnya Bharambe, Fortrea | |
Dipen Kachhiapatel, Syndax and Mathura P Ramanathan | |
Zhaojuan Meng, Sanofi and Suresh Yenishetty, IQVIA | |
iADRG | Christine Rossin and Kiran Kundarapu, Loxooncology |
Venkat Rajesh Datla, Genmab and Priyanka Pollarine, Biogen |
Regulatory Referenced Deliverables | Representatives | |
---|---|---|
Sumit Pradhan, Syneos Health and Pradnya Bharambe, Fortrea | ||
Dipen Kachhiapatel, Syndax and Mathura P Ramanathan | ||
Zhaojuan Meng, Sanofi and Suresh Yenishetty, IQVIA | ||
iADRG | Christine Rossin and Kiran Kundarapu, Loxooncology | |
Venkat Rajesh Datla, Genmab and Priyanka Pollarine, Biogen |